Duke Clinical Research Institute, Durham, NC, United States of America.
Duke Clinical Research Institute, Durham, NC, United States of America.
Prog Cardiovasc Dis. 2019 Jul-Aug;62(4):306-314. doi: 10.1016/j.pcad.2019.07.001. Epub 2019 Jul 10.
Cardiovascular disease (CVD) is the most common cause of morbidity and mortality for patients with diabetes mellitus (DM). Although the burden of atherosclerotic CVD (ASCVD) is well documented, heart failure (HF) has been an under-appreciated CVD complication of DM. However, as more patients with DM live longer and survive acute ASCVD events, the distribution of CVD complications has evolved. This review summarizes the epidemiology of DM, the relative risk and prognosis of both ASCVD and HF following a diagnosis of DM, and the likelihood of cause-specific CVD mortality in patients with DM.
心血管疾病(CVD)是糖尿病(DM)患者发病率和死亡率的最常见原因。尽管动脉粥样硬化性心血管疾病(ASCVD)的负担有充分的记录,但心力衰竭(HF)一直是 DM 的一种被低估的 CVD 并发症。然而,随着更多的 DM 患者活得更长,并且从急性 ASCVD 事件中存活下来,CVD 并发症的分布已经发生了变化。这篇综述总结了 DM 的流行病学,DM 患者诊断后 ASCVD 和 HF 的相对风险和预后,以及 DM 患者特定原因 CVD 死亡率的可能性。